{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T08:54:13Z","timestamp":1765961653880,"version":"3.40.5"},"reference-count":62,"publisher":"Informa UK Limited","issue":"4","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Drug Safety"],"published-print":{"date-parts":[[2023,4,3]]},"DOI":"10.1080\/14740338.2023.2203481","type":"journal-article","created":{"date-parts":[[2023,4,15]],"date-time":"2023-04-15T14:51:04Z","timestamp":1681570264000},"page":"271-277","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":5,"title":["Benefit and risk evaluation of quinapril hydrochloride"],"prefix":"10.1080","volume":"22","author":[{"given":"Maryam","family":"Barkhordarian","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Hackensack Meridian Health - Palisades Medical Center, North Bergen, NJ, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jannel A.","family":"Lawrence","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Ross University School of Medicine, Largo, MD, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebahat","family":"Ulusan","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Suleyman Demirel University School of Medicine, Isparta, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammed Ibrahim","family":"Erbay","sequence":"additional","affiliation":[{"name":"Cerrahpasa School of Medicine Istanbul, Istanbul University Cerrahpasa, Istanbul, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wilbert S.","family":"Aronow","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Westchester Medical Center, New York, NY, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2511-2119","authenticated-orcid":false,"given":"Rahul","family":"Gupta","sequence":"additional","affiliation":[{"name":"Lehigh Valley Heart Institute, Lehigh Valley Health Network, Allentown, PA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2023,4,17]]},"reference":[{"key":"e_1_3_5_3_1","unstructured":"PubChem [Internet]. Bethesda (MD): National Library of Medicine (US) National Center for Biotechnology Information; 2004. . PubChem Compound Summary for CID 54891 Quinapril hydrochloride; [cited 2022 Nov. 10]. Available from: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Quinapril-hydrochloride."},{"key":"e_1_3_5_4_1","volume-title":"Treasure Island","author":"Tandan N","year":"2022","unstructured":"Tandan N, Cassagnol M. Treasure Island. Tampa, Florida: StatPearls Publishing LLC; 2022."},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1177\/000331978904000410"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.1177\/000331978904000405"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.1177\/000331978904000406"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/clc.4960131408"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-6175.2007.06949.x"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.94.3.258"},{"issue":"4","key":"e_1_3_5_11_1","first-page":"CD001841","article-title":"First-line drugs for hypertension","volume":"18","author":"Wright JM","year":"2018","unstructured":"Wright JM, Musini VM, Gill R. First-line drugs for hypertension. Cochrane Database Syst Rev. 2018;18(4):CD001841.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.1097\/00045391-199705000-00004"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.27147"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1995.03520420066040"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.060068"},{"issue":"18","key":"e_1_3_5_16_1","first-page":"e895","article-title":"AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"145","author":"Heidenreich PA","year":"2022","unstructured":"Heidenreich PA, Bozkurt B, Aguilar D, et al. AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022;145(18):e895\u2013e1032.","journal-title":"Circulation"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab368"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc18-S010"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8227(02)00154-7"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10157-018-1567-1"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(99)00537-9"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(98)00862-5"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-200206000-00009"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.1081\/JCMR-100107470"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00447.2006"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199448020-00008"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200262020-00009"},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199141030-00006"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199243010-00009"},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199549050-00008"},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199549030-00008"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(87)90050-6"},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0031-1300539"},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199142030-00008"},{"key":"e_1_3_5_35_1","doi-asserted-by":"publisher","DOI":"10.1002\/bdd.2510100404"},{"key":"e_1_3_5_36_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-198835060-00003"},{"key":"e_1_3_5_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1982.tb01991.x"},{"key":"e_1_3_5_38_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-198836050-00003"},{"key":"e_1_3_5_39_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.3.4.456"},{"key":"e_1_3_5_40_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-198631030-00002"},{"key":"e_1_3_5_41_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1986.tb05205.x"},{"key":"e_1_3_5_42_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199448010-00007"},{"key":"e_1_3_5_43_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-199406001-00009"},{"key":"e_1_3_5_44_1","first-page":"839","article-title":"Formulary forum","volume":"23","author":"Michael J","year":"1989","unstructured":"Michael J. Formulary forum. Ann Pharmacother. 1989;23:839\u2013846.","journal-title":"Ann Pharmacother"},{"key":"e_1_3_5_45_1","doi-asserted-by":"publisher","DOI":"10.1002\/j.1552-4604.1987.tb03037.x"},{"key":"e_1_3_5_46_1","doi-asserted-by":"publisher","DOI":"10.1093\/ajh\/3.11S.278S"},{"key":"e_1_3_5_47_1","doi-asserted-by":"publisher","DOI":"10.1517\/17425250903282773"},{"key":"e_1_3_5_48_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1990.tb03767.x"},{"key":"e_1_3_5_49_1","doi-asserted-by":"publisher","DOI":"10.1002\/j.1552-4604.1990.tb03574.x"},{"issue":"10","key":"e_1_3_5_50_1","first-page":"46C","article-title":"Adverse effects of angiotensin-converting enzyme inhibitors in antihypertensive therapy with focus on quinapril","volume":"69","author":"Materson BJ","year":"1992","unstructured":"Materson BJ. Adverse effects of angiotensin-converting enzyme inhibitors in antihypertensive therapy with focus on quinapril. Am J Hypertens. 1992;69(10):46C\u201353C.","journal-title":"Am J Hypertens"},{"key":"e_1_3_5_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(92)91065-9"},{"issue":"6","key":"e_1_3_5_52_1","first-page":"VII19","article-title":"The safety and efficacy of quinapril in the treatment of mild to moderate essential hypertension","volume":"13","author":"Frishman WH","year":"1990","unstructured":"Frishman WH. The safety and efficacy of quinapril in the treatment of mild to moderate essential hypertension. Clin Cardiol. 1990;13(6 Suppl 7):VII19\u201325.","journal-title":"Clin Cardiol"},{"key":"e_1_3_5_53_1","unstructured":"labeling.pfizer.com [Internet]. Parke-Davis div of pfizer inc: [cited 2022 Dec 5]. Available from: https:\/\/labeling.pfizer.com\/ShowLabeling.aspx?id=518"},{"key":"e_1_3_5_54_1","doi-asserted-by":"publisher","DOI":"10.1080\/03007995.2021.1971183"},{"key":"e_1_3_5_55_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1997.03890440040006"},{"key":"e_1_3_5_56_1","unstructured":"Goyal A Cusick AS Thielemier B. ACE inhibitors [Internet]. StatPearls [Internet]. [cited 2022 Dec 1]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK430896\/"},{"key":"e_1_3_5_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.reprotox.2011.02.008"},{"key":"e_1_3_5_58_1","first-page":"107","article-title":"Angiotensin-converting enzyme inhibition in renal disease; contrasting effects on renal function in renal artery stenosis and progressive renal injury","volume":"3","author":"Jackson B","year":"1989","unstructured":"Jackson B, Johnston CI. Angiotensin-converting enzyme inhibition in renal disease; contrasting effects on renal function in renal artery stenosis and progressive renal injury. J Hum Hypertens. 1989;3 Suppl 1:107\u2013115.","journal-title":"J Hum Hypertens"},{"key":"e_1_3_5_59_1","doi-asserted-by":"publisher","DOI":"10.1177\/0091270002239820"},{"issue":"1","key":"e_1_3_5_60_1","first-page":"53","article-title":"Angiotensin converting enzyme inhibition and renal insufficiency in patients with bilateral renovascular disease","volume":"2","author":"Dominiczak A","year":"1988","unstructured":"Dominiczak A, Isles C, Gillen G, et al. Angiotensin converting enzyme inhibition and renal insufficiency in patients with bilateral renovascular disease. J Hum Hypertens. 1988;2(1):53\u201356.","journal-title":"J Hum Hypertens"},{"issue":"3","key":"e_1_3_5_61_1","first-page":"185","article-title":"Occlusion of unilateral stenosed renal arteries\u2013relation to medical treatment","volume":"3","author":"Postma CT","year":"1989","unstructured":"Postma CT, Hoefnagels WH, Barentsz JO, et al. Occlusion of unilateral stenosed renal arteries\u2013relation to medical treatment. J Hum Hypertens. 1989;3(3):185\u2013190.","journal-title":"J Hum Hypertens"},{"key":"e_1_3_5_62_1","first-page":"87","article-title":"Effects of the angiotensin-converting enzyme inhibitor quinapril on renal function in rats","volume":"324","author":"Graziano MJ","year":"1993","unstructured":"Graziano MJ, Dethloff LA, Griffin HE, et al. Effects of the angiotensin-converting enzyme inhibitor quinapril on renal function in rats. Arch Int Pharmacodyn Ther. 1993;324:87\u2013104.","journal-title":"Arch Int Pharmacodyn Ther"},{"issue":"5","key":"e_1_3_5_63_1","first-page":"838","article-title":"A postmarketing surveillance evaluation of quinapril in 3742 Canadian hypertensive patients: the ACCEPT study. accupril Canadian clinical evaluation and patient teaching","volume":"16","author":"Larochelle P","year":"1994","unstructured":"Larochelle P, Haynes B, Maron N, et al. A postmarketing surveillance evaluation of quinapril in 3742 Canadian hypertensive patients: the ACCEPT study. accupril Canadian clinical evaluation and patient teaching. Clin Ther. 1994;16(5):838\u2013853.","journal-title":"Clin Ther"},{"key":"e_1_3_5_64_1","doi-asserted-by":"publisher","DOI":"10.1177\/000331978904000404"}],"container-title":["Expert Opinion on Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14740338.2023.2203481","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T19:56:03Z","timestamp":1726602963000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14740338.2023.2203481"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,3]]},"references-count":62,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4,3]]}},"alternative-id":["10.1080\/14740338.2023.2203481"],"URL":"https:\/\/doi.org\/10.1080\/14740338.2023.2203481","relation":{},"ISSN":["1474-0338","1744-764X"],"issn-type":[{"type":"print","value":"1474-0338"},{"type":"electronic","value":"1744-764X"}],"subject":[],"published":{"date-parts":[[2023,4,3]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieds20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieds20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2022-12-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-04-12","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-04-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}